ASTH vs XRAY · P/E 34, rev $1.94B vs rev $1.78B
Astrana Health Inc (ASTH) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Astrana Health Inc (ASTH) is a medical care facilities company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported ASTH revenue for 2026-06-30 was $1.94B. Net income was $34.2M. ASTH currently screens at market cap $1.13B and trailing P/E 33.5.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
ASTH currently screens at market cap $1.13B and trailing P/E 33.5. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the ASTH and XRAY stock pages for the full models.
Not investment advice.